Latest filing published 08 Sept 2026 for Iradimed CORP, €76k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Monty K. Allen, listed as board member, appears in our data through filings on Iradimed Corp shares, published by SEC (Form 4). We count 16 filings; the first trade dates from 3 August 2021 and the latest from 3 September 2026.
On the market, this insider has only sold: 8 sales, €604k in total. Besides market trades, the filings include 8 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
On 8 September 2026 came the latest disclosure, an open-market sale for €76k in Iradimed Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations